Compare companies
Enter two imported ticker symbols or CIK identifiers.
| Metric | REGENERON PHARMACEUTICALS, INC. | Company B |
|---|---|---|
| Revenue | $14342900000 (Dec. 31, 2025) | — |
| Net Income | $4504900000 (Dec. 31, 2025) | — |
| Assets | $40558700000 (Dec. 31, 2025) | — |
| Liabilities | $9301800000 (Dec. 31, 2025) | — |
| Operating Income | $3577900000 (Dec. 31, 2025) | — |
| Cash | $3118100000 (Dec. 31, 2025) | — |
| Operating Cash Flow | $4978900000 (Dec. 31, 2025) | — |
Periods may differ. Do not interpret comparisons as period-aligned until dates are matched.